Literature DB >> 2156735

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.

L Buscail1, P Gourlet, A Cauvin, P De Neef, D Gossen, A Arimura, A Miyata, D H Coy, P Robberecht, J Christophe.   

Abstract

We characterized highly selective receptors for PACAP, the pituitary adenylate cyclase activating peptide, in the tumoral acinar cell line AR 4-2J derived from the rat pancreas. PACAP, a novel hypothalamic peptide related to vasoactive intestinal peptide (VIP), was tested as the full natural 38-residue peptide (PACAP-38) and as an N-terminal amidated 27-residue derivative (PACAP-27). The binding sites showed considerable affinity for [125I]PACAP-27 (Kd = 0.4 nM) and PACAP-38, while their affinity for VIP and the parent peptide helodermin was 1000-fold lower. These receptors were coupled to adenylate cyclase, the potency of PACAP-38 and PACAP-27 (Kact = 0.2 nM) being much higher than that of VIP (Kact = 100 nM) and helodermin (Kact = 30 nM). Chemical cross-linking of [125I]PACAP-27 followed by SDS-PAGE and autoradiography revealed a specifically cross-linked peptide with an Mr of 68,000 (including 3000 for one PACAP-27 molecule).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156735     DOI: 10.1016/0014-5793(90)80158-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Trophic effects of PACAP on pancreatic islets: a mini-review.

Authors:  Yusuke Sakurai; Norihito Shintani; Atsuko Hayata; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

2.  Pituitary adenylate cyclase-activating polypeptide regulates brain-derived neurotrophic factor exon IV expression through the VPAC1 receptor in the amphibian melanotrope cell.

Authors:  Adhanet H Kidane; Eric W Roubos; Bruce G Jenks
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

3.  Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.

Authors:  J R Pisegna; S A Wank
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Pituitary adenylate cyclase activating polypeptide is a potent vasodilator and oedema potentiator in rabbit skin in vivo.

Authors:  J B Warren; S W Larkin; M Coughlan; R Kajekar; T J Williams
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

5.  Pituitary adenylate cyclase activating polypeptides, PACAP-27 and PACAP-38: stimulators of electrogenic ion secretion in the rat small intestine.

Authors:  H M Cox
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

7.  Cells retrovirally transfected with fibroblast growth factor-2 isoforms exhibit altered adenylate cyclase activity and G-protein functionality.

Authors:  A Estival; P Robberecht; M Fanjul; B Rouot; E Hollande; N Vaysse; F Clemente
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

Review 8.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

9.  Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors.

Authors:  Shiva Kumar; Augen Pioszak; Chenghai Zhang; Kunchithapadam Swaminathan; H Eric Xu
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

10.  The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.

Authors:  N Zeng; T Kang; R M Lyu; H Wong; Y Wen; J H Walsh; G Sachs; J R Pisegna
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.